Serial Number
90263391
Owner
Design Therapeutics, Inc.Attorney
Aaron D. HendelmanFirst Use Date
Aug 5, 2024
Filing Date
Oct 19, 2020
GENETAC Trademark
Serial Number: 90263391 • Registration: 7599711
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
October 19, 2020
Registration Date
December 10, 2024
First Use Anywhere
August 5, 2024
First Use in Commerce
August 5, 2024
Published for Opposition
May 4, 2021
Goods & Services
pharmaceutical preparations for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; therapeutic pharmaceuticals for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; small molecule therapies for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
pharmaceutical research and products development for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development of therapeutics for the treatment of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; research and development in the field of small molecule therapeutics; scientific research for medical purposes in the field of degenerative disorders and diseases, genetic disorders and diseases, and disorders and diseases caused by transcriptional dysregulation; medical and scientific research in the field of pharmaceuticals, all of the foregoing related to therapies that target nucleic acids and modulate gene expression
